来自非常小的儿科捐赠者的En-bloc脏移植:一个倾向性得分匹配分析
Silvia Oberparleiter1, Felix J Krendl1, Thomas Resch1
1Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Frontiers in pediatrics
|May 12, 2025
概括
从小儿捐赠者≤2年进行的En-bloc移植 (EBKT) 在成年接受者中提供了卓越的长期功能. 尽管最初出现并发症,EBKT显示患者和移植的存活率与标准标准供体移植 (SKT) 相当.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植手术 移植手术
- 儿科器官捐赠儿童器官捐赠
背景情况:
- 来自小儿科捐赠者 (≤2岁) 的脏通常被认为是移植的边缘脏.
- 区块内移植 (EBKT) 涉及将两个从一个小捐赠者的移植为一个单位.
- 本研究将儿科捐赠者≤2岁的EBKT结果与成年接受者捐赠移植 (SKT) 的标准标准进行比较.
研究的目的:
- 分析和比较EBKT从非常小的儿科捐赠者与SKT的中期和长期结果.
- 评估患者存活率,移植存活率和EBKT和SKT后的功能.
主要方法:
- 从一个单一中心前性收集数据库的回顾性分析 (2015年1月 - 2017年6月).
- 包括从2岁以下的儿科捐赠者获得的6个EBKT和75个到成年接受者的SKT.
- 使用倾向分数匹配 (PSM) 来最大限度地减少选择偏差.
主要成果:
- 在74个月的中位数随访后,EBKT显示了100%的5年患者和移植生存率.
- SKT显示5年患者和死亡审查的移植存活率为94.7%.
- 与SKT相比,EBKT接受者在74个月内 (107 vs. 52 ml/min/1.73m2,p < 0.001) 的估计球过率 (eGFR) 中位数显著更高,尽管在移植后初始降低了eGFR.
结论:
- 来自非常小小的儿科捐赠者的En-bloc脏移植产生了优秀的长期功能.
- 虽然术后并发症 (如动脉血栓形成) 可能发生,但它们不会对中期患者和移植物的生存产生负面影响.
- EBKT是利用边缘儿科器官的可行选择,提供优越的长期功能.
相关概念视频
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...